Generative AI of the “large language” kind has been an attention hog over the past 10 or 11 months. The buzz has been so loud and constant that it’s all but asking to be dismissed as hype.

Do you know who owns your personal favorite doctor’s practice? Could it be a healthcare conglomerate? An insurance company? A private equity firm? Amazon?

Last week brought the latest in an occasional series of conversations on AI between governmental leaders and Big Tech honchos.

Almost 80% of provider organizations spent more on IT systems and software this year than last, yet only 6% have a plan in hand to incorporate generative AI into their digital ecosystem.

AI is accelerating genomic medicine’s advance into the promised land of personalized, predictive and preventive care.

Whichever AI segment you follow most closely, be it healthcare or any other, you had to pause to absorb this week’s financial report from Nvidia.

The two companies continue to expand their partnership, this time looking to deploy generative AI to improve care delivery.

AI that’s intended to let cars drive themselves can be repurposed to let tanks level cities. And AI can just as easily weaponize a virus as diagnose it. These are not secrets.